We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

83 hedge funds and large institutions have $57.2M invested in Antares Pharma, Inc. in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 22

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less funds holding

Funds holding: 88 → 83 (-5)

28% less capital invested

Capital invested by funds: $79.4M → $57.2M (-$22.2M)

31% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 16

Holders
83
Holders Change
-5
Holders Change %
-5.68%
% of All Funds
2.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
30
Reduced
22
Closed
16
Calls
$44K
Puts
–
Net Calls
+$44K
Net Calls Change
-$52K

Top Buyers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
+$3.49M
2
Morgan Stanley
Morgan Stanley
New York
+$2.47M
3
AC
Armistice Capital
New York
+$2.1M
4
Renaissance Technologies
Renaissance Technologies
New York
+$818K
5
PAM
Panagora Asset Management
Massachusetts
+$412K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$4.82M
2
Millennium Management
Millennium Management
New York
-$2.62M
3
LOAMU
Lombard Odier Asset Management (USA)
New York
-$1.26M
4
KCM
Kingdon Capital Management
New York
-$688K
5
TI
Turner Investments
Pennsylvania
-$537K
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
26
AllianceBernstein
Tennessee
$163K -$9.68K -10,000 -5%
Deutsche Bank
27
Deutsche Bank
Germany
$146K -$22.6K -23,369 -12%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$132K -$24.7K -25,497 -14%
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$131K – – –
JAM
30
JW Asset Management
Florida
$124K – – –
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$123K – – –
Citigroup
32
Citigroup
New York
$120K +$72.8K +75,259 +120%
Manulife (Manufacturers Life Insurance)
33
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$92K +$2.88K +2,971 +3%
NFA
34
Nationwide Fund Advisors
Ohio
$92K +$5.44K +5,626 +6%
SG Americas Securities
35
SG Americas Securities
New York
$90K +$99.8K +103,113 New
OC
36
Oppenheimer & Co
New York
$82K -$7.74K -8,000 -8%
VOYA Investment Management
37
VOYA Investment Management
Georgia
$81K – – –
AIG
38
American International Group
New York
$79K – – –
BA
39
BlackRock Advisors
Delaware
$67K +$9.78K +10,102 +15%
Jacobs Levy Equity Management
40
Jacobs Levy Equity Management
New Jersey
$66K +$72.9K +75,300 New
State Board of Administration of Florida Retirement System
41
State Board of Administration of Florida Retirement System
Florida
$64K – – –
NPC
42
National Planning Corporation
California
$61K -$645 -667 -1%
SIC
43
SFE Investment Counsel
California
$52K – – –
DCM
44
DAFNA Capital Management
California
$39K – – –
Commonwealth Equity Services
45
Commonwealth Equity Services
Massachusetts
$38K – – –
Two Sigma Investments
46
Two Sigma Investments
New York
$35K -$18.2K -18,785 -32%
LPL Financial
47
LPL Financial
California
$35K +$25.2K +26,006 +173%
Invesco
48
Invesco
Georgia
$34K -$3.06K -3,162 -7%
SI
49
SII Investments
Wisconsin
$31K +$20.8K +21,500 +185%
Principal Financial Group
50
Principal Financial Group
Iowa
$30K +$3.08K +3,179 +10%
1
2
3 4

ATRS Hedge Fund Activity: Q1 2016 in Review

83 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q1 2016, worth a combined $57.2M — down 28% from $79.4M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ATRS and 11 opened new positions — a net loss of 5 holders — while 22 trimmed existing stakes and 30 added.

The largest buyer was Broadfin Capital, adding an estimated $3.49M. The largest seller was Deerfield Management, exiting entirely with an estimated $4.82M sold.

  • 83 institutional investors held Antares Pharma, Inc. (ATRS) as of Q1 2016, down from 88 in Q4 2015.
  • Funds reported $57.2M of Antares Pharma, Inc. stock for Q1 2016, down 28% quarter-over-quarter.
  • 11 funds opened new Antares Pharma, Inc. positions in Q1 2016 and 16 closed out, a net change of -5 holders.
  • The largest Antares Pharma, Inc. buyer in Q1 2016 was Broadfin Capital, an estimated $3.49M added.
  • The largest Antares Pharma, Inc. seller in Q1 2016 was Deerfield Management, an estimated $4.82M sold.

Based on aggregated 13F filings for Q1 2016.